[A phase I study of subcutaneous envafolimab (KN035) monotherapy in Chinese patients with advanced solid tumors].
Autorzy:
LiuRR; Department of Medical Oncology, Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China. Gu SZ; Department of Interventional Radiology, Hunan Cancer Hospital, Changsha 410031, China. Zhou T; Department of Urology, Changhai Hospital of Shanghai, Shanghai 200433, China. Lin LZ; Cancer Center, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China. Chen WC; Department of Gastroenterology, First Affiliated Hospital to Soochow University, Suzhou 215006, China. Zhong DS; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China. Liu TS; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Yang N; Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Changsha 410031, China. Shen L; Department of Gastrointestinal Oncology, Peking University Cancer Hospital, Beijing 100142, China. Xu SY; 3D Medicines Co. Ltd, Chengdu 610036, China. Lu N; 3D Medicines Co. Ltd, Chengdu 610036, China. Zhang Y; 3D Medicines Co. Ltd, Chengdu 610036, China. Gong ZL; 3D Medicines Co. Ltd, Chengdu 610036, China. Xu JM; Department of Medical Oncology, Senior Department of Oncology, the Fifth Medical Center of PLA General Hospital, Beijing 100071, China.
LncRNA FGD5-AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR-223 and regulating the expression of ECT2 and FAT1.
Autorzy:
He CK; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. Li ZB; Department of Emergency, Xiangya Hospital, Central South University, Changsha, Hunan Province, China. Yi D; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. Zhu XY; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. LiuRR; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. Zhang DX; Department of Nuclear Medicine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. Cao Q; Department of Endocrine, Hunan Provincial People's Hospital, Changsha, Hunan Province, China. Chen YP; Medical Laboratory, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Post-radiation circulating tumor DNA as a prognostic factor in locally advanced esophageal squamous cell carcinoma.
Autorzy:
Jia R; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China. Zhao CH; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China. Li PS; Geneplus-Beijing Institute, Changping, Beijing 102206, P.R. China. LiuRR; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China. Zhang Y; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China. Chen HE; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China. Chang LP; Geneplus-Beijing Institute, Changping, Beijing 102206, P.R. China. Gong YH; Geneplus-Beijing Institute, Changping, Beijing 102206, P.R. China. Guan YF; Geneplus-Beijing Institute, Changping, Beijing 102206, P.R. China. Yi X; Geneplus-Beijing Institute, Changping, Beijing 102206, P.R. China. Xu JM; Department of Gastrointestinal Oncology, The Fifth Medical Centre, Chinese People's Liberation Army General Hospital, Fengtai, Beijing 100071, P.R. China.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2021 Jan; Vol. 21 (1), pp. 68. Date of Electronic Publication: 2020 Nov 25.
Study of the controversial resveratrol that interact with the endogenous glutathione thiyl radical in cancer cells.
Autorzy:
Yin B; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China. LiuRR; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China. Meng YJ; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China. Zhai HL; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China. Li SS; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China. Muhire J; College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, PR China.
Pokaż więcej
Źródło:
Free radical research [Free Radic Res] 2020 Sep; Vol. 54 (8-9), pp. 687-693. Date of Electronic Publication: 2020 Oct 13.
Efficacy research of salazosulfamide in ankylosing spondylitis and NAT1 gene polymorphism.
Autorzy:
Ma XF; Division of Immunology and Rheumatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China. Wang XD; Division of Immunology and Rheumatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China. LiuRR; Division of Immunology and Rheumatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China. Luan QX; Division of Immunology and Rheumatology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China.
Cascading failures in coupled networks: The critical role of node-coupling strength across networks.
Autorzy:
LiuRR; Alibaba Research Center for Complexity Sciences, Hangzhou Normal University, Hangzhou, 311121, People's Republic of China. Li M; School of Engineering Science, University of Science and Technology of China, Hefei, 230026, People's Republic of China. Jia CX; Alibaba Research Center for Complexity Sciences, Hangzhou Normal University, Hangzhou, 311121, People's Republic of China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Oct 17; Vol. 6, pp. 35352. Date of Electronic Publication: 2016 Oct 17.
Analysis of the genetic variants associated with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy: A case report.
Autorzy:
Sun NA; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China. Cheng P; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China. Deng DH; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China. LiuRR; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China. Lai YR; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Pokaż więcej
Źródło:
Biomedical reports [Biomed Rep] 2016 Jul; Vol. 5 (1), pp. 23-26. Date of Electronic Publication: 2016 May 12.
Cascading failures in coupled networks with both inner-dependency and inter-dependency links.
Autorzy:
LiuRR; Alibaba Research Center for Complexity Sciences, Hangzhou Normal University, Hangzhou, 311121, People's Republic of China. Li M; Department of Modern Physics, University of Science and Technology of China, Hefei, 230026, People's Republic of China.; Department of Applied Physics, Hong Kong Polytechnic University, Hung Hom, Hong Kong. Jia CX; Alibaba Research Center for Complexity Sciences, Hangzhou Normal University, Hangzhou, 311121, People's Republic of China. Wang BH; Department of Modern Physics, University of Science and Technology of China, Hefei, 230026, People's Republic of China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 May 04; Vol. 6, pp. 25294. Date of Electronic Publication: 2016 May 04.
The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients.
Autorzy:
Xiao D; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Guo Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Li X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Yin JY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Zheng W; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Qiu XW; Changsha Medical University Teaching Hospital, The People's Hospital of Liuyang, Liuyang 410300, China. Xiao L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. LiuRR; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Wang SY; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Gong WJ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Zhou HH; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China. Liu ZQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China; Institute of Clinical Pharmacology, Central South University and Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China; Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study, Hengyang 421001, China.
Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature.
Autorzy:
Lin LI; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Xu CW; Department of Pathology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Zhang BO; Department of Pathology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. LiuRR; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Ge FJ; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Zhao CH; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Jia RU; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Qin QH; Department of Pathology, Tianjin First Center Hospital, Tianjin 30000, P.R. China. Stojsic J; Service of Histopathology, Clinical Centre of Serbia, Belgrade 11000, Serbia. Wang Y; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China. Xu JM; Department of Gastrointestinal Oncology, Affiliated Hospital Cancer Center, Academy of Military Medical Sciences, Beijing 100071, P.R. China.
Integrated analysis of microRNA and mRNA expression profiles in abdominal adipose tissues in chickens.
Autorzy:
Huang HY; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China.; Institute of Poultry Science, Chinese Academy of Agriculture Sciences, Yangzhou 225125, P. R. China. LiuRR; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China. Zhao GP; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China. Li QH; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China. Zheng MQ; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China. Zhang JJ; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China. Li SF; Institute of Poultry Science, Chinese Academy of Agriculture Sciences, Yangzhou 225125, P. R. China. Liang Z; Institute of Poultry Science, Chinese Academy of Agriculture Sciences, Yangzhou 225125, P. R. China. Wen J; Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, P.R. China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2015 Nov 04; Vol. 5, pp. 16132. Date of Electronic Publication: 2015 Nov 04.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
